HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liang Yu Selected Research

QX-222 (QX 222)

1/2014Coapplication of lidocaine and membrane-impermeable lidocaine derivative QX-222 produces divergent effects on evoked and spontaneous nociceptive behaviors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liang Yu Research Topics

Disease

68Neoplasms (Cancer)
12/2022 - 10/2003
21Inflammation (Inflammations)
04/2022 - 01/2013
19Neoplasm Metastasis (Metastasis)
06/2022 - 04/2008
17COVID-19
01/2022 - 01/2020
16Infections
01/2022 - 12/2011
14Stomach Neoplasms (Stomach Cancer)
07/2022 - 07/2008
12Carcinogenesis
01/2022 - 12/2009
11Breast Neoplasms (Breast Cancer)
10/2022 - 12/2009
9Lung Neoplasms (Lung Cancer)
10/2022 - 04/2008
9Hepatocellular Carcinoma (Hepatoma)
06/2022 - 10/2003
8Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 04/2008
8Carcinoma (Carcinomatosis)
07/2014 - 12/2009
7Leukemia
12/2022 - 02/2015
7Liver Cirrhosis (Hepatic Cirrhosis)
04/2022 - 12/2010
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 09/2017
6Body Weight (Weight, Body)
01/2019 - 06/2009
6Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018 - 01/2013
5Multiple Myeloma
10/2022 - 02/2016
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2022 - 02/2016
5Cytokine Release Syndrome
07/2021 - 01/2020
5Pain (Aches)
03/2021 - 01/2014
5Fibrosis (Cirrhosis)
01/2021 - 08/2010
5Ischemia
01/2018 - 02/2009
4Adenocarcinoma of Lung
01/2022 - 04/2008
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 01/2017
4Thrombosis (Thrombus)
08/2020 - 05/2009
4Prostatic Neoplasms (Prostate Cancer)
07/2020 - 08/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019 - 03/2008
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 04/2008
4Human Influenza (Influenza)
01/2018 - 02/2015
4Type 2 Diabetes Mellitus (MODY)
10/2017 - 10/2013
4Hypopharyngeal Neoplasms
07/2014 - 02/2012
3Liver Neoplasms (Liver Cancer)
06/2022 - 10/2003
3Non-alcoholic Fatty Liver Disease
04/2022 - 09/2020
3Hypoxia (Hypoxemia)
04/2022 - 10/2009
3Disease Progression
04/2022 - 05/2011
3Pathologic Processes
01/2022 - 09/2017
3Melanoma (Melanoma, Malignant)
01/2022 - 01/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 06/2009
3Autoimmune Diseases (Autoimmune Disease)
12/2021 - 01/2018
3Rectal Neoplasms (Rectal Cancer)
09/2021 - 10/2020
3Pathologic Complete Response
04/2021 - 02/2013
3Epilepsy (Aura)
01/2021 - 02/2012
3Liver Diseases (Liver Disease)
01/2021 - 11/2004
3Hematologic Neoplasms (Hematological Malignancy)
06/2020 - 02/2019
3Coinfection
01/2020 - 01/2016
3Shock
01/2020 - 06/2013
3Hypertension (High Blood Pressure)
01/2020 - 12/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2019 - 01/2019
3Brain Injuries (Brain Injury)
01/2019 - 01/2017
3Cognitive Dysfunction
01/2019 - 11/2017
3Influenza in Birds (Avian Flu)
01/2018 - 02/2016

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
12/2022 - 10/2003
17Messenger RNA (mRNA)IBA
04/2022 - 03/2008
17Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
11CytokinesIBA
07/2022 - 01/2017
10MicroRNAs (MicroRNA)IBA
10/2022 - 03/2016
10Pharmaceutical PreparationsIBA
01/2022 - 03/2005
9Biological ProductsIBA
10/2020 - 10/2008
7Therapeutic UsesIBA
12/2021 - 10/2004
6RNA (Ribonucleic Acid)IBA
07/2022 - 07/2017
6EnzymesIBA
01/2022 - 04/2011
6ResveratrolIBA
01/2016 - 10/2003
5Long Noncoding RNAIBA
07/2022 - 08/2017
5LipidsIBA
04/2022 - 06/2009
5Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 12/2009
5Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2008
5CateninsIBA
09/2021 - 12/2013
5C-Reactive ProteinIBA
03/2021 - 06/2009
5Indicators and Reagents (Reagents)IBA
09/2020 - 08/2010
5Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019 - 02/2015
4Phosphotransferases (Kinase)IBA
07/2022 - 06/2011
4Antiviral Agents (Antivirals)IBA
09/2021 - 02/2015
4Interleukin-6 (Interleukin 6)IBA
07/2021 - 01/2017
4Small Interfering RNA (siRNA)IBA
07/2019 - 09/2013
4salicylhydroxamic acid (SHAM)IBA
01/2018 - 02/2009
3CholesterolIBA
12/2022 - 06/2009
3bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
04/2022 - 01/2016
3Imatinib Mesylate (Gleevec)FDA Link
12/2021 - 01/2017
3ibrutinibIBA
01/2021 - 06/2017
3Circular RNAIBA
01/2021 - 12/2019
3Agammaglobulinaemia Tyrosine KinaseIBA
01/2021 - 01/2020
3ProcalcitoninIBA
01/2021 - 02/2016
3Valproic Acid (Depakote)FDA LinkGeneric
01/2021 - 02/2012
3Viral RNAIBA
10/2020 - 01/2020
3Blood Glucose (Blood Sugar)IBA
08/2020 - 06/2009
3Peptide Hydrolases (Proteases)FDA Link
01/2020 - 06/2018
3BilirubinIBA
01/2020 - 10/2013
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2019 - 03/2009
3InterleukinsIBA
01/2019 - 01/2012

Therapy/Procedure

44Therapeutics
04/2022 - 05/2004
12Drug Therapy (Chemotherapy)
10/2021 - 10/2004
7Artificial Liver (Bioartificial Liver)
07/2021 - 11/2004
6Liver Transplantation
10/2021 - 11/2004
5Transplantation
04/2021 - 11/2004
4Immunotherapy
01/2022 - 01/2014
4Islets of Langerhans Transplantation
10/2015 - 01/2014
3Neoadjuvant Therapy
09/2021 - 10/2020
3Hematopoietic Stem Cell Transplantation
03/2021 - 02/2016
3Artificial Respiration (Mechanical Ventilation)
01/2020 - 02/2016